$XLO

Xilio Therapeutics Advances Cancer Treatment With Novel Tumor-activated Immunotherapies

$XLO Xilio Therapeutics, Inc. (Nasdaq:XLO), a pioneering biotechnology firm, announced the initiation of three preclinical programs for masked T cell…